CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
Generated Narrative: Medication
Resource Medication "Medication-Peri-Transplant-Example"
Profile: CIBMTR Additional Drugs in Peri-Transplant Period
Security Labels: http://terminology.cibmtr.org/codesystem/transplant-center
code: anti-thymocyte globulin Injection (RxNorm#2282515 "lymphocyte immune globulin, anti-thymocyte globulin Injectable Product"; RxNorm#2282516 "lymphocyte immune globulin, anti-thymocyte globulin Injection"; RxNorm#2282518 "lymphocyte immune globulin, anti-thymocyte globulin, equine 50 MG/ML [ATGAM]"; RxNorm#2282519 "lymphocyte immune globulin, anti-thymocyte globulin Injection [ATGAM]")
| - | Item[x] | Strength |
| * | anti-thymocyte globulin Injection (RxNorm#2282515 "lymphocyte immune globulin, anti-thymocyte globulin Injectable Product"; RxNorm#2282516 "lymphocyte immune globulin, anti-thymocyte globulin Injection"; RxNorm#2282518 "lymphocyte immune globulin, anti-thymocyte globulin, equine 50 MG/ML [ATGAM]"; RxNorm#2282519 "lymphocyte immune globulin, anti-thymocyte globulin Injection [ATGAM]") | 50 milligram (Details: UCUM code mg = 'mg')/1 milliliter (Details: UCUM code mL = 'mL') |